Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

Sharjah Police foil two cocaine smuggling operations, seize 17kg
DP World installs first 1,000 living seawalls panels at Jebel Ali Port
UAE 'an exceptional model' in developing AI policies, says Omar Al Olama
Sheikh Mohammed honours Egyptian professor with 'Great Arab Minds' award
UAE announces $550 million for UN’s 2026 Global Humanitarian Overview